News

GLP-1 Medications and Endoscopic Sleeve: How They Can Work Together for Weight Loss

View Content

For many people, weight loss is not a straight line. Some start with lifestyle changes, others begin treatment with GLP-1 medications and others explore procedural options when they want additional support. According to Vladimir M. Kushnir, MD, a WashU Medicine gastroenterologist, these options do not have to compete with one another. In many cases, they can work together.

Understanding the Endoscopic Sleeve

The endoscopic sleeve is a minimally invasive, non-surgical weight loss procedure performed through the mouth using a tube called a flexible endoscope. A specialized device is used to place shoelace-like stitches in the stomach, reducing its volume by about two-thirds.

No part of the stomach is removed. The stitches bring the stomach walls together, creating a sleeve-like shape that limits how much food can be eaten at one time.

The procedure:

  • Takes about one hour
  • Usually an outpatient procedure
  • Requires no incisions (cuts)
  • Typically allows the patient to return to work within three to five days

Most patients follow a liquid diet for a short time after the procedure, then transition back to regular reduced-calorie meals.

How Much Weight Loss Is Typical?

Weight loss varies from person to person. Research data shows weight loss of approximately 15 percent of total body weight after an endoscopic sleeve by itself. For comparison, GLP-1 medications may result in 10 to 20 percent total body weight loss.

Can GLP-1 Medications and Endoscopic Sleeve Be Combined?

Yes. At WashU Medicine, Dr. Kushnir offers ways to these approaches together.

Some common scenarios include:

  • Patients who are on GLP-1 medications but want additional weight loss support
  • Patients who could not tolerate GLP-1 medications and are seeking a non-surgical option
  • Patients who have undergone endoscopic sleeve and later add a GLP-1 to help reach or maintain weight goals

When combined thoughtfully, total weight loss can approach 30 percent or more. GLP-1 medications are paused for about two weeks before and after the procedure to reduce nausea and allow healing.

Who Is a Candidate?

The endoscopic sleeve has been studied primarily in patients with a body mass index between 30 and 50. Many insurance plans use similar BMI thresholds as bariatric surgery for coverage, though coverage varies by plan and carrier.

The ideal candidate is someone who:

  • Has a BMI between 30 and 50
  • Is seeking a minimally invasive option
  • Is committed to lifestyle changes including nutrition and exercise

Lifestyle Changes Still Matter

The endoscopic sleeve is a tool, not a standalone solution.

Physicians emphasize:

  • Reduced calorie intake
  • Adequate protein
  • Weight-bearing exercise to preserve muscle mass

This is especially important when using GLP-1 medications, as rapid weight loss without strength training can result in muscle loss.

Safety and Recovery

Serious complications from endoscopic sleeve are rare, occurring in less than three percent of cases and typically requiring no more than short hospital observation.

Most patients appreciate that the procedure:

  • Does not require incisions
  • Does not permanently remove any part of the stomach
  • Allows a relatively quick return to normal activities
  • Can be reversed if needed

A Personalized Approach

Weight loss is a personal journey. For many patients, effective treatment requires a combination of tools. GLP-1 medications and endoscopic sleeve procedures don’t have to be one or the other. When used together thoughtfully, they may provide additional support for patients working toward meaningful, sustained weight loss.

To find out if this approach is right for you, call 314-362-2652, visit Dr. Kushnir’s webpage or request a weight loss consultation today.